| Literature DB >> 11792319 |
Hai-Ying M Cheng1, Graham M Pitcher, Steven R Laviolette, Ian Q Whishaw, Kit I Tong, Lisa K Kockeritz, Teiji Wada, Nicholas A Joza, Michael Crackower, Jason Goncalves, Ildiko Sarosi, James R Woodgett, Antonio J Oliveira-dos-Santos, Mitsuhiko Ikura, Derek van der Kooy, Michael W Salter, Josef M Penninger.
Abstract
Control and treatment of chronic pain remain major clinical challenges. Progress may be facilitated by a greater understanding of the mechanisms underlying pain processing. Here we show that the calcium-sensing protein DREAM is a transcriptional repressor involved in modulating pain. dream(-/-) mice displayed markedly reduced responses in models of acute thermal, mechanical, and visceral pain. dream(-/-) mice also exhibited reduced pain behaviors in models of chronic neuropathic and inflammatory pain. However, dream(-/-) mice showed no major defects in motor function or learning and memory. Mice lacking DREAM had elevated levels of prodynorphin mRNA and dynorphin A peptides in the spinal cord, and the reduction of pain behaviors in dream(-/-) mice was mediated through dynorphin-selective kappa (kappa)-opiate receptors. Thus, DREAM appears to be a critical transcriptional repressor in pain processing.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11792319 DOI: 10.1016/s0092-8674(01)00629-8
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582